Found 878 matching trials
Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)
NATo investigate the feasibility and peri-operative complications of preopera...
Location
Radiotherapy Department of Cancer Hospital, Chinese Academy of Medical Sciences
Immune Boost In Non-Small Cell Lung Cancer
NAInsufficient migration and activation of tumour specific effector T cells s...
Location
Department of Thoracic Surgery, Thoraxklinik, University Hospital Heidelberg
Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
PHASE1The purpose of this study is to determine treatment related toxicity, tumor...
Location
Methodist University Hospital
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.
PHASE2This study is a multicenter, prospective, randomized, double-arm, Phase II ...
Location
Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651
Hypoxia-targeted Radiotherapy Boost for GBM
NAThe purpose of this study is to evaluate the use of dynamic contrast-enhanc...
Location
NYU Langone Health
Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE2Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregional...
Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer
NAHYPO-RT-PC boost is is an open-label, multicentre, phase II trial evaluatin...
Location
Region Skåne, Skåne University Hospital
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
N/AThe primary objective of this study is to evaluate the prediction of late t...
Location
CRLC Val d'Aurelle
Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer
PHASE2The goal of this clinical trial is to learn whether new adjuvant radiothera...
Location
Multiple Locations
Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)
PHASE1A Phase I of Olaparib with Radiation Therapy in Patients With Inflammatory,...